The median OS across all cohorts was 19 months, which compares favorably to historical OS of five months for patients with ATC. The longest OS among the cohorts was 43.2 months in patients with ...
The longest OS among the cohorts was 43.2 months in patients with BRAFV600E mutations—the longest OS published to date for systematic therapy in ATC. "Patients with anaplastic thyroid carcinoma ...